Investigator
Richard F Lewis
MASSACHUSETTS EYE AND EAR INFIRMARY · funded by NIDCD
- Companies
- 3
- Grants
- 3
- Non-dilutive funding
- $1.2M
- First award
- Sep 1, 2024
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest May 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- MASSACHUSETTS EYE AND EAR INFIRMARY30momentum
OncologyGrant-only
- MASSACHUSETTS EYE AND EAR INFIRMARYMomentum in another area
NeuroGrant-only
- MASSACHUSETTS EYE AND EAR INFIRMARYMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Vestibular dysfunction in patients with sporadic vestibular schwannomas and NF2-related schwannomatosis.
$620kMay 1, 2025NIDCDMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11047133 (opens the source filing in a new tab)
- R01
Vestibular implant tested in patients with peripheral vestibular damage: effects on spatial orientation, navigation, and neuropsychologic function
$509kSep 1, 2024NIDCDMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11177904 (opens the source filing in a new tab)
- R01
Vestibular implant tested in patients with peripheral vestibular damage: effects on spatial orientation, navigation, and neuropsychologic function
$112kSep 1, 2024NIDCDMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11371741 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources